Skip to main content
Fig. 4 | SpringerPlus

Fig. 4

From: miR-125b-1 is repressed by histone modifications in breast cancer cell lines

Fig. 4

An inhibitor of EZH2 reactivates miR-125b-1 in MCF7 breast cancer cells. To determine the dose of GSK126 that reduces H3K27me3 levels, we treated the breast cell lines with different GSK126 concentrations and performed Western blot analysis (a). b Densitometric analysis of triplicate Western blots. We chose the 1000-nM dose to evaluate pri-miR-125b-1 (c) and mature miR-125b expression levels (d)

Back to article page